Insider Transactions in Q3 2024 at Guardant Health, Inc. (GH)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 04
2024
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+0.64%
|
-
|
Jul 01
2024
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
758
-2.86%
|
$21,224
$28.26 P/Share
|
Jul 01
2024
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,928
+6.78%
|
-
|
Jul 01
2024
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
574
-3.1%
|
$16,072
$28.26 P/Share
|
Jul 01
2024
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,607
+7.98%
|
-
|
Jul 01
2024
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
348
-1.18%
|
$9,744
$28.26 P/Share
|
Jul 01
2024
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
974
+3.21%
|
-
|
Jul 01
2024
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
478
-1.07%
|
$13,384
$28.26 P/Share
|
Jul 01
2024
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,339
+2.92%
|
-
|
Jul 01
2024
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
612
-3.2%
|
$17,136
$28.26 P/Share
|
Jul 01
2024
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,714
+8.23%
|
-
|